Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Illinois offers various clinical research options, including those for healthy volunteers interested in paid studies, as well as for individuals with specific health conditions. Leading research centers in Chicago, Plainfield, and Springfield are actively seeking participants, providing access to innovative treatments and personalized care.
Filter
1
Filter results
Results: 2,591
Dupilumab in the Treatment of Pediatric Alopecia Areata
for
Alopecia Areata
Location: New York NY, Chicago IL, San Diego CA, Irvine CA
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 6 - 17
Code: NCT05866562
Phase 2, Recruiting
Patient Pain and Function in Medial Knee Osteoarthritis After Anteromedial vs Anterolateral Intra-Articular Corticosteroid Injection
A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis
for
FSGS
Location: New York NY, Chicago IL
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07213960
Phase 2, Phase 3, Recruiting
Assessment of a Method to Improve Cochlear Implant Users' Speech Perception in Noisy Environments While Maintaining Their Ability to Determine Where a Sound Originates From
for
Cochlear Implant Users
Location: Champaign IL
Sponsor: University of Illinois at Urbana-Champaign
Sex: All
Age: 18+
Code: NCT07323862
Recruiting
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
for
Heart Failure With Preserved Ejection Fraction
Location: Birmingham AL, Peoria IL, Houma LA, Vista CA
Sponsor: Edgewise Therapeutics, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07795814
Phase 2, Recruiting
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Morehead City NC, Newport News VA, New Bern NC,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase 2, Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: Cromwell CT, New York NY, Chapel Hill NC, Peterborough,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07783542
Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
for
Locally Advanced Adrenal Cortical Carcinoma,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT06900595
Phase 2, Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400